Zemethis 15 | 30 | 60 | 120 mg
Antiemetic Neurokinin-1 (NK-1) Receptor Antagonist
Soft Chews
Each chewable tablet contains:
Zemethis® 15 mg: Maropitant (as maropitant citrate) 15 mg.
Zemethis® 30 mg: Maropitant (as maropitant citrate) 30 mg.
Zemethis® 60 mg: Maropitant (as maropitant citrate) 60 mg.
Zemethis® 120 mg: Maropitant (as maropitant citrate) 120 mg.
For the treatment and prevention of chemotherapy-induced nausea; prevention of vomiting except for that induced by motion sickness (sickness); prevention and treatment of vomiting, in combination with other adjunctive measures; prevention of perioperative nausea and vomiting and improvement in recovery from general anesthesia after the use of morphine, a μ-opioid receptor agonist.
Oral route. Prevention of motion sickness: 8 mg/kg (the tablet can be split for greater dosage accuracy).
Zemethis® 15 mg: Chemotherapy-related vomiting and other vomiting: Minimum dose of 2 mg/kg (1 tablet for dogs weighing 3.75–7.5 kg).
Zemethis® 30 mg: Chemotherapy-related vomiting and other vomiting: Minimum dose of 2 mg/kg (1 tablet for dogs weighing 7.5–15 kg).
Zemethis® 60 mg: Chemotherapy-related vomiting and other vomiting: Minimum dose of 2 mg/kg (1 tablet for dogs weighing 15–30 kg).
Zemethis® 120 mg: Chemotherapy-related vomiting and other vomiting: Minimum dose of 2 mg/kg (1 tablet for dogs weighing 30–60 kg).
Box of 1 or 4 soft chewable tablets in sealed aluminum blister pack of 1 g., Box of 1 or 4 soft chewable tablets in sealed aluminum blister pack of 2 g..
SENASA Registry: F.043.031.N.00026.
Print
Insert
ShareThis content is informative reference and should not be considered as prescriptions.
